Sargent Investment Group’s Matinas BioPharma MTNB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.36K	Hold	12,720	–	–	﹤0.01%	269
2025 Q4	$7.45K	Sell	12,720 -23,900	-65%	-$28.2K	﹤0.01%	261
2025 Q3	$69.2K	Buy	36,620 +1,000	+3%	+$1.44K	0.01%	118
2025 Q2	$32.1K	Sell	35,620 -6,180	-15%	-$4.53K	﹤0.01%	234
2025 Q1	$21.7K	Sell	41,800 -22,400	-35%	-$13.3K	﹤0.01%	231
2024 Q4	$38.4K	Sell	64,200 -16,040	-20%	-$24.4K	0.01%	232
2024 Q3	$284K	Buy	80,240 +10,400	+15%	+$66.2K	0.05%	171
2024 Q2	$553K	Sell	69,840 -2,370	-3%	-$21.5K	0.11%	114
2024 Q1	$978K	Sell	72,210 -4,150	-5%	-$49.3K	0.21%	82
2023 Q4	$825K	Sell	76,360 -2,100	-3%	-$23.7K	0.18%	99
2023 Q3	$510K	Hold	78,460	–	–	0.12%	115
2023 Q2	$1.41M	Sell	78,460 -6,580	-8%	-$153K	0.34%	62
2023 Q1	$2.08M	Sell	85,040 -2,661	-3%	-$67.2K	0.55%	44
2022 Q4	$2.19M	Buy	87,701 +3,554	+4%	+$118K	0.68%	39
2022 Q3	$2.9M	Buy	84,147 +4,929	+6%	+$194K	0.9%	31
2022 Q2	$3.13M	Buy	79,218 +6,338	+9%	+$242K	0.97%	29
2022 Q1	$2.93M	Buy	72,880 +302	+0.4%	+$11.1K	0.74%	34
2021 Q4	$3.67M	Buy	72,578 +7,678	+12%	+$410K	0.84%	31
2021 Q3	$4.22M	Buy	64,900 +21,012	+48%	+$907K	1.03%	30
2021 Q2	$1.7M	Buy	43,888 +3,708	+9%	+$159K	0.41%	48
2021 Q1	$2.11M	Buy	40,180 +11,589	+41%	+$777K	0.56%	41
2020 Q4	$1.94M	Buy	28,591 +13,141	+85%	+$609K	0.62%	36
2020 Q3	$592K	Buy	15,450 +9,159	+146%	+$364K	0.22%	87
2020 Q2	$246K	Buy	6,291 +2,450	+64%	+$93.9K	0.09%	129
2020 Q1	$115K	Buy	3,841 +2,724	+244%	+$164K	0.05%	133
2019 Q4	$127K	Buy	+1,117	New	+$64.7K	0.05%	149